🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan flag Japan · Delayed Price · Currency is JPY
1,842.50
-53.00 (-2.80%)
Nov 20, 2026, 9:20 AM JST

Sumitomo Pharma Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
77,75944,31036,28829,047143,478202,984
Cash & Short-Term Investments
77,75944,31036,28829,047143,478202,984
Cash Growth
102.02%22.11%24.93%-79.75%-29.32%4.79%
Accounts Receivable
152,046114,20271,51981,02395,908151,407
Other Receivables
24520,48512,76316,2162,72293
Receivables
152,291134,68784,28297,23998,630151,500
Inventory
90,48585,41496,917115,35094,40599,021
Other Current Assets
16,83114,84133,68227,93345,34746,016
Total Current Assets
337,366279,252253,168269,569381,860499,521
Property, Plant & Equipment
44,29544,23146,64857,89558,90964,091
Long-Term Investments
106,91936,4005,588182,368144,399127,909
Goodwill
207,678211,098197,406199,783209,415195,144
Other Intangible Assets
154,039160,474172,509195,652329,314398,692
Long-Term Deferred Tax Assets
7564215342,23910,84522,650
Other Long-Term Assets
-72,69566,751---
Total Assets
851,053804,571742,604907,5061,134,7421,308,007

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
61,77812,0839,22567,72052,14146,183
Short-Term Debt
20,00038,13042,440174,58890,5885,025
Current Portion of Long-Term Debt
--4,000110,929-20,060
Current Portion of Leases
-1,9143,3543,7814,6605,463
Current Income Taxes Payable
5,0901,1201,5771,34824,0537,583
Other Current Liabilities
161,056218,253180,007157,108199,446194,059
Total Current Liabilities
247,924271,500240,603515,474370,888278,373
Long-Term Debt
119,692179,056258,982133,367244,128243,963
Long-Term Leases
-5,1165,4705,1996,99610,033
Pension & Post-Retirement Benefits
5,6435,6636,53411,1505,00811,461
Long-Term Deferred Tax Liabilities
14,92215,83626,55038,21136,50526,550
Other Long-Term Liabilities
31,76734,93334,98647,96964,43564,058
Total Liabilities
419,948512,104573,125751,370727,960634,438

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
71,32122,40022,40022,40022,40022,400
Additional Paid-In Capital
48,258----16,725
Retained Earnings
200,284158,98146,784-22,665280,999514,210
Treasury Stock
-685-684-682-682-682-681
Comprehensive Income & Other
111,927111,770100,977157,010104,03255,234
Total Common Equity
431,105292,467169,479156,063406,749607,888
Minority Interest
---733365,681
Shareholders' Equity
431,105292,467169,479156,136406,782673,569
Total Liabilities & Equity
851,053804,571742,604907,5061,134,7421,308,007

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
139,692224,216314,246427,864346,372284,544
Net Cash (Debt)
-61,933-179,906-277,958-398,817-202,894-81,560
Net Cash Growth
------
Net Cash Per Share
-147.56-452.83-699.64-1003.84-510.69-205.29
Filing Date Shares Outstanding
448.59397.29397.29397.29397.29397.29
Total Common Shares Outstanding
448.59397.29397.29397.29397.29397.29
Working Capital
89,4427,75212,565-245,90510,972221,148
Book Value Per Share
961.02736.16426.59392.821023.801530.08
Tangible Book Value
69,388-79,105-200,436-239,372-131,98014,052
Tangible Book Value Per Share
154.68-199.11-504.51-602.51-332.2035.37
Land
-1,5221,452---
Buildings
-69,97568,001---
Machinery
-72,65774,020---
Construction In Progress
-9,9229,468---